DC-Research Knowledge Portal: Advanced prostate carcinoma DC vaccine

has knowledgeable contact person

Daniela Rozková

Institute of Immunology 2nd Medical School, Charles University
Jirina Bartunkova

Scientific responsible

Institute of Immunology 2nd Medical School, Charles University

is input of ProtocolStep

Vaccination of patients

vaccination step

is output of ProtocolStep

Cell pulsing

adding substance to cell culture step

Bio Materials > molecular structure > Molecular entity > vaccine > Advanced prostate carcinoma...

Advanced prostate carcinoma DC vaccine

vaccine

The vaccine is composed by autologous DCs pulsed with apoptotic allogenic prostate carcinoma cell line LNCap. It is used for vaccination of patients with advanced prostate carcinoma.

created over 16 years ago (2 March 2009) last modified over 13 years ago (28 September 2011) [ RDF ] [ RelFinder ]


User Id
Password
Remember me on this computer


Show tooltips:
Show Atlas results:
Show DC-Base results: